advertisement

---

Molecular therapy. Methods & clinical development 6

Showing records 1 to 6 | Display all abstracts in Molecular therapy. Methods & clinical development

73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Fujita K
Molecular therapy. Methods & clinical development 2017; 5: 130-141

---

73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Cwerman-Thibault H; Lechauve C
Molecular therapy. Methods & clinical development 2017; 5: 200-220

---

73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Nishiguchi KM; Shiga Y
Molecular therapy. Methods & clinical development 2017; 5: 130-141

---

73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Augustin S
Molecular therapy. Methods & clinical development 2017; 5: 200-220

---

73013 Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury
Nakazawa T
Molecular therapy. Methods & clinical development 2017; 5: 130-141

---

73139 Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice
Roussel D; Reboussin É; Mohammad A; Degardin-Chicaud J; Simonutti M; Liang H; Brignole-Baudouin F; Maron A; Debeir T; Corral-Debrinski M
Molecular therapy. Methods & clinical development 2017; 5: 200-220

---